Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Corrigendum to "A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles" [Virology 507 (2017) 242-256].

Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Esteban M, Blattman JN, Jacobs BL, Mor TS.

Virology. 2019 Jun 6. pii: S0042-6822(19)30139-4. doi: 10.1016/j.virol.2019.05.018. [Epub ahead of print] No abstract available.

PMID:
31178060
2.

Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.

Asbach B, Kibler KV, Köstler J, Perdiguero B, Yates NL, Stanfield-Oakley S, Tomaras GD, Kao SF, Foulds KE, Roederer M, Seaman MS, Montefiori DC, Parks R, Ferrari G, Forthal DN, Phogat S, Tartaglia J, Barnett SW, Self SG, Gottardo R, Cristillo AD, Weiss DE, Galmin L, Ding S, Heeney JL, Esteban M, Jacobs BL, Pantaleo G, Wagner R.

J Virol. 2019 Jan 17;93(3). pii: e01529-18. doi: 10.1128/JVI.01529-18. Print 2019 Feb 1.

PMID:
30429343
3.

Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.

Kibler KV, Asbach B, Perdiguero B, García-Arriaza J, Yates NL, Parks R, Stanfield-Oakley S, Ferrari G, Montefiori DC, Tomaras GD, Roederer M, Foulds KE, Forthal DN, Seaman MS, Self S, Gottardo R, Phogat S, Tartaglia J, Barnett S, Cristillo AD, Weiss D, Galmin L, Ding S, Heeney JL, Esteban M, Wagner R, Pantaleo G, Jacobs BL.

J Virol. 2019 Jan 17;93(3). pii: e01513-18. doi: 10.1128/JVI.01513-18. Print 2019 Feb 1.

PMID:
30429340
4.

Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.

Koehler H, Cotsmire S, Langland J, Kibler KV, Kalman D, Upton JW, Mocarski ES, Jacobs BL.

Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11506-11511. doi: 10.1073/pnas.1700999114. Epub 2017 Oct 9.

5.

A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.

Meador LR, Kessans SA, Kilbourne J, Kibler KV, Pantaleo G, Roderiguez ME, Blattman JN, Jacobs BL, Mor TS.

Virology. 2017 Jul;507:242-256. doi: 10.1016/j.virol.2017.04.008. Epub 2017 Apr 28. Erratum in: Virology. 2019 Jun 6;:.

6.

HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.

García-Arriaza J, Perdiguero B, Heeney JL, Seaman MS, Montefiori DC, Yates NL, Tomaras GD, Ferrari G, Foulds KE, Roederer M, Self SG, Borate B, Gottardo R, Phogat S, Tartaglia J, Barnett SW, Burke B, Cristillo AD, Weiss DE, Lee C, Kibler KV, Jacobs BL, Wagner R, Ding S, Pantaleo G, Esteban M.

J Virol. 2017 Apr 13;91(9). pii: e02182-16. doi: 10.1128/JVI.02182-16. Print 2017 May 1.

7.

Monkeypox virus induces the synthesis of less dsRNA than vaccinia virus, and is more resistant to the anti-poxvirus drug, IBT, than vaccinia virus.

Arndt WD, White SD, Johnson BP, Huynh T, Liao J, Harrington H, Cotsmire S, Kibler KV, Langland J, Jacobs BL.

Virology. 2016 Oct;497:125-135. doi: 10.1016/j.virol.2016.07.016. Epub 2016 Jul 26.

8.

A Designed "Nested" Dimer of Cyanovirin-N Increases Antiviral Activity.

Woodrum BW, Maxwell J, Allen DM, Wilson J, Krumpe LR, Bobkov AA, Hill RB, Kibler KV, O'Keefe BR, Ghirlanda G.

Viruses. 2016 Jun 6;8(6). pii: E158. doi: 10.3390/v8060158.

9.

Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.

Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, Huynh TP, Jacobs BL.

J Virol. 2015 Oct;89(20):10489-99. doi: 10.1128/JVI.00304-15. Epub 2015 Aug 5.

10.

Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.

Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M.

J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14. Epub 2014 Oct 29.

11.

Effect of hepatitis C infection on HIV-induced apoptosis.

Laskus T, Kibler KV, Chmielewski M, Wilkinson J, Adair D, Horban A, Stańczak G, Radkowski M.

PLoS One. 2013 Oct 1;8(10):e75921. doi: 10.1371/journal.pone.0075921. eCollection 2013.

12.

Improved NYVAC-based vaccine vectors.

Kibler KV, Gomez CE, Perdiguero B, Wong S, Huynh T, Holechek S, Arndt W, Jimenez V, Gonzalez-Sanz R, Denzler K, Haddad EK, Wagner R, Sékaly RP, Tartaglia J, Pantaleo G, Jacobs BL, Esteban M.

PLoS One. 2011;6(11):e25674. doi: 10.1371/journal.pone.0025674. Epub 2011 Nov 9.

13.

Improved innate and adaptive immunostimulation by genetically modified HIV-1 protein expressing NYVAC vectors.

Quakkelaar ED, Redeker A, Haddad EK, Harari A, McCaughey SM, Duhen T, Filali-Mouhim A, Goulet JP, Loof NM, Ossendorp F, Perdiguero B, Heinen P, Gomez CE, Kibler KV, Koelle DM, Sékaly RP, Sallusto F, Lanzavecchia A, Pantaleo G, Esteban M, Tartaglia J, Jacobs BL, Melief CJ.

PLoS One. 2011 Feb 15;6(2):e16819. doi: 10.1371/journal.pone.0016819.

14.

Vaccinia virus vaccines: past, present and future.

Jacobs BL, Langland JO, Kibler KV, Denzler KL, White SD, Holechek SA, Wong S, Huynh T, Baskin CR.

Antiviral Res. 2009 Oct;84(1):1-13. doi: 10.1016/j.antiviral.2009.06.006. Epub 2009 Jun 26. Review.

15.

Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection.

Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki M, Radkowski M, Nasseri J, Rakela J, Laskus T.

J Viral Hepat. 2006 Jul;13(7):489-98.

PMID:
16792543
16.

The N-terminus of rodent and human MAD1 confers species-specific stringency to spindle assembly checkpoint.

Haller K, Kibler KV, Kasai T, Chi YH, Peloponese JM, Yedavalli VS, Jeang KT.

Oncogene. 2006 Apr 6;25(15):2137-47.

PMID:
16288203
17.

Human T-cell leukemia virus type I: 25 years of progress and challenges.

Kibler KV, Jeang KT.

J Biomed Sci. 2005;12(1):7-11. Review. No abstract available.

PMID:
15864735
18.

Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection.

Kibler KV, Miyazato A, Yedavalli VS, Dayton AI, Jacobs BL, Dapolito G, Kim SJ, Jeang KT.

J Biol Chem. 2004 Nov 19;279(47):49055-63. Epub 2004 Sep 14.

19.

Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.

Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE.

J Infect Dis. 2004 Jun 1;189(11):2037-46. Epub 2004 May 10.

PMID:
15143471
20.

Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax and TNFalpha: implications for stimulus-specific interruption of oncogenic signaling.

Iha H, Kibler KV, Yedavalli VR, Peloponese JM, Haller K, Miyazato A, Kasai T, Jeang KT.

Oncogene. 2003 Dec 4;22(55):8912-23.

PMID:
14654787
21.

Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells.

Löhr M, Kibler KV, Zachary I, Jeang KT, Selwood DL.

Biochem Biophys Res Commun. 2003 Jan 10;300(2):609-13.

PMID:
12504126
22.
23.

Pleiotropic effects of HTLV type 1 Tax protein on cellular metabolism: mitotic checkpoint abrogation and NF-kappaB activation.

Iha H, Kasai T, Kibler KV, Iwanaga Y, Tsurugi K, Jeang KT.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1633-8.

PMID:
11080803
24.

Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation.

Jin DY, Wang HL, Zhou Y, Chun AC, Kibler KV, Hou YD, Kung H, Jeang KT.

EMBO J. 2000 Feb 15;19(4):729-40.

25.
26.

Taxing the cellular capacity for repair: human T-cell leukemia virus type 1, DNA damage, and adult T-cell leukemia.

Kibler KV, Jeang KT.

J Natl Cancer Inst. 1999 Jun 2;91(11):903-4. No abstract available.

PMID:
10359537
27.

Complementation of vaccinia virus deleted of the E3L gene by mutants of E3L.

Shors T, Kibler KV, Perkins KB, Seidler-Wulff R, Banaszak MP, Jacobs BL.

Virology. 1997 Dec 22;239(2):269-76.

28.

Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells.

Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL.

J Virol. 1997 Mar;71(3):1992-2003.

Supplemental Content

Loading ...
Support Center